Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?

The prevention and control of vector-borne diseases is a priority for improving global health. Despite recent advances in the characterization of ectoparasite-host-pathogen molecular interactions, vaccines are not available for most ectoparasites and vector-borne diseases that cause millions of deat...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Fuente, José, Estrada-Peña, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789832/
https://www.ncbi.nlm.nih.gov/pubmed/31357707
http://dx.doi.org/10.3390/vaccines7030075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789832/
https://www.ncbi.nlm.nih.gov/pubmed/31357707
http://dx.doi.org/10.3390/vaccines7030075

Ejemplares similares